5 Experimental SMA Therapies You Might Find Interesting

1. AVXS 101

news_18_Artboard 343 copy 347

Recently, AveXis’ gene therapy candidate AVXS-101, the only gene therapy for spinal muscular atrophy currently in human testing, has been granted FDA orphan drug status for treatment of all types of SMA. It was also granted FDA breakthrough therapy designation and fast track designation. Read about it and other SMA therapy developments here.

Find out more on how AVXS 101 can be used to treat SMA.

Leave a Comment

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This